Changes in FA metabolism enzymes have also been reported in prostate cancer, where elevated expression of ACSL1 was associated with serum acyl-CoA levels, which promoted cancer progression via augmented β-oxidation and lipogenesis [97]. The gene discussed is ACSL1; the disease is prostate cancer.